Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Zyomyx, EMD Biosciences


Agilent Technologies this week officially launched its LC/MDS XCT Plus ion trap mass spectrometer, after unofficially announcing the launch at Pittcon last month (see PM 3-12-04). The XCT Plus is four times more sensitive than the original XCT model, according to the company.

The company also released LC/MSD Trap Security Pack 1.0 software for use with its ion traps. The software includes the following features for CFR Part 11 compliance: storage of all metadata and audit logs, limited system access, simple user management administration, protection of electronic records, time-stamped, user-independent audit trails, operational system checks, and electronic signaling.

Zyomyx has launched its Murine Cytokine Biochip. The chip allows for the analysis of 30 mouse cytokines, chemokines, and growth factors, using sample volumes of 40 microliters, according to the company. The release follows on last year’s release of a Human Cytokine Biochip, and can be used with Zyomyx’ Assay 1200 Biochip Workstation and Scanner 100 Biochip Reader.

EMD Biosciences has launched its ProteoPlex 16-Well Human Cytokine Array Kit. The kit allows for the determination of levels of 12 cytokines from 10 sera or tissue culture supernatants, requiring 50 microliters of sample material, according to the company.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.